Souria Dougherty, MBA
About Souria Dougherty, MBA
Souria Dougherty, MBA, serves as the Executive Director of Clinical Science at Geron Corporation, a position she has held since 2019. With extensive experience in clinical research and development, she has worked at several prominent companies including Covance, GSK, Janssen Pharmaceuticals, and Genmab.
Current Role at Geron Corporation
Souria Dougherty serves as the Executive Director of Clinical Science at Geron Corporation. She has held this position since 2019, contributing to the company's clinical development initiatives. In this role, she oversees clinical research strategies and ensures the successful execution of clinical trials, aligning with Geron's mission to advance innovative therapies.
Previous Experience in Clinical Research
Before joining Geron Corporation, Souria Dougherty accumulated extensive experience in clinical research. She worked at Covance Periapproval Services Inc. as a Senior Clinical Research Associate from 2001 to 2006. Following this, she held the position of Clinical Development Manager (Associate Director) at GSK from 2007 to 2015, where she managed clinical development projects. She also served as Director of Clinical Science at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2015 to 2019.
Educational Background
Souria Dougherty earned her Master of Business Administration (MBA) from Villanova University. She also completed her Bachelor of Science (B.S.) in Comprehensive Science at the same institution. Her educational background provides a strong foundation for her career in clinical science and management.
Career Progression
Souria Dougherty's career in clinical research began at Covance Periapproval Services Inc., where she worked for five years. She then transitioned to Genmab as a Project Manager for one year before taking on a more senior role at GSK. Her career continued to advance with her position at The Janssen Pharmaceutical Companies, culminating in her current role at Geron Corporation.